Richard Lowenthal

Mr. Richard E.
Lowenthal is a Chief Executive Officer & Director at ARS Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at ARS Pharmaceuticals Operations, Inc. He is on the Board of Directors at ARS Pharmaceuticals, Inc. and ARS Pharmaceuticals Operations, Inc. Mr. Lowenthal was previously employed as a President & Chief Executive Officer by MTG Biotherapeutics, Inc., a President by Pacific-Link Regulatory Consulting, a President-Pacific Link Regulatory Consulting by Research, Inc., a VP-Regulatory Affairs & Quality Assurance by Cadence Pharmaceuticals, Inc., a Head-Worldwide Regulatory Affairs & Drug Safety by Maxim Pharmaceuticals, Inc., a VP-Regulatory Affairs & Quality Assurance by AnGes MG, Inc., a Director-Regulatory Affairs & Quality Assurance by Somerset Pharmaceuticals, Inc., a Global Director-Regulatory Affairs by The Janssen Research Foundation, a Chairman by American Association of Pharmaceutical Scientists, a Member-Corporate Council by The National Organization for Rare Disorders, Inc., and a Regulatory Affairs Officer by Vecta Ltd. He also served on the board at Momotaro-Gene, Inc. He received his graduate degree from Florida State University and a graduate degree from the University of San Diego.